TherapeuticsMD Shares Up 45% Into Last Hour Of Mon.-Morning Trade; Hearing Cowen Analyst Boosted Price Target On Stock From $13 To $16, Maintained Buy; BZ NOTE: New Target Represents Possible Upside Of ~155%
Paul Quintaro